Legal & General Group Plc - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 65 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$15,000
-51.6%
3,994
-22.1%
0.00%
Q4 2019$31,0000.0%5,128
+23.4%
0.00%
Q3 2019$31,000
-34.0%
4,155
+20.1%
0.00%
Q2 2019$47,000
+123.8%
3,460
+42.0%
0.00%
Q1 2018$21,000
-30.0%
2,4360.0%0.00%
Q4 2017$30,000
+114.3%
2,436
+45.0%
0.00%
Q3 2017$14,000
-53.3%
1,6800.0%0.00%
Q2 2017$30,0001,6800.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders